Dr. Gayatri Iyer | Pharmacogenomics | Best Researcher Award
Scientist III, Tata Institute for Genetics and Society, India.
Dr. Gayatri R. Iyer (MSc, PhD), a passionate genetic scientist and DST-INSPIRE Fellow, specializes in rare genetic disorders, molecular diagnostics, and genetic counseling. As a Scientist Grade III at the Tata Institute for Genetics and Society, Bangalore, she is actively involved in advancing affordable genetic testing solutions. A certified Level II Genetic Counselor and Executive Council Member of BGC-I, she’s dedicated to integrating advanced research with clinical care, genetic counseling, and patient advocacy, especially for rare disorders. Her work bridges research, diagnostics, and clinical application seamlessly. 🌟🧬
Professional Profile
🎓 Education
Dr. Iyer holds a PhD in Human Genetics from Kamineni Hospitals, affiliated with Osmania University, Hyderabad (2016-2021), supported by a prestigious DST-INSPIRE Fellowship. She earned her MSc in Applied Genetics from The Oxford College of Science, Bangalore (2012-2014), where she was a Gold Medalist, and a BSc in Biotechnology from Birla College, Mumbai University (2012), securing second rank. Additionally, she has completed multiple certifications, including a PG Certificate in Medical & Genetic Counseling and a Diploma in Bioinformatics. 🎓📖
💼 Experience
Dr. Iyer has diverse research and clinical experience. She is currently a Scientist Grade III at TIGS, Bangalore (2025–present), focusing on rare genetic disorders using long-read sequencing and pharmacogenomics. Previously, she held roles as Scientist Grade II and Postdoctoral Fellow in proteomics and biomarker discovery. She has provided genetic counseling in top hospitals and conducted over 2,000 counseling sessions across pediatric, oncology, and obstetric settings. Her teaching experience spans molecular diagnostics and genetic counseling. 🧪👩⚕️
🔬 Research Interests
Dr. Iyer’s research interests include genetic counseling, pharmacogenomics, molecular diagnostics, next-generation sequencing, microarray technology, epigenetics, and genomic imprinting. She focuses on developing cost-effective diagnostic methods for rare disorders, studying the psychosocial and ethical aspects of genetic testing, and applying advanced molecular tools for precision medicine. 🔍🧬
🏆 Awards
📚 Top Noted Publications
Cataloging Actionable Pharmacogenomic Variants for Indian Clinical Practice: A Scoping Review. J. Xenobiot. 2025 – Cited by multiple pharmacogenomic studies.
Targeted proteomics for classifying meningioma tumors. Clinical Proteomics. 2023 – Referenced in proteomics research.
Telegenetics aids Hunter syndrome diagnosis in rural India. Int J Contemp Pediatr. 2022 – Discussed in pediatric genetics circles.
Next-generation sequencing utility in musculoskeletal disorders. J Orthop Surg Res. 2022 – Widely cited in genetic diagnostics.
Clinico-molecular spectrum of Angelman syndrome involving GABRG3 gene. Ann Hum Genet. 2021 – Referenced in epigenetics research.